Sekhmet Pharmaventures

Premium
Bottomline: Low demand weighs on PE-backed Anjan Drug's revenue

Healthcare

02 July, 2025

Bottomline: Low demand weighs on PE-backed Anjan Drug's revenue

Anjan Drug, a PAG-backed active pharmaceutical ingredient (API) manufacturer, reported a decline in revenue for the ......

Premium

Healthcare

02 September, 2024

Exclusive: PE-backed platforms in fray for API maker Aurore Life

Hyderabad-based bulk-drugs maker Aurore Life Sciences has attracted interest from a number of suitors ......

Finance

29 May, 2023

PAG-backed Sekhmet appoints former Jubilant Ingrevia head as CEO

Sekhmet Pharmaventures, a pharmaceutical investment platform backed by Asia-Pacific focused private equity investor PAG......

Healthcare

26 September, 2022

PAG-led consortium completes $260 mn deal with Optimus

Asia Pacific-focused investment firm PAG, along with consortium partners CX Partners and Samara Capital, has completed ......

Healthcare

11 May, 2022

PAG consortium to acquire controlling stake in Optimus group firms

PAG, alternative investment firm focused on Asia-Pacific, today announced that it has agreed to acquire publicly listed Unichem...

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News